Italian €170m reimbursement fraud investigation deepens
This article was originally published in Clinica
Executive Summary
Ongoing investigations in Italy surrounding the alleged reimbursement of medical procedures that were not performed, totalling over €170m ($220m), have resulted in the arrest of at least 13 officials. They are said to include the director-general of the national health service's Rome "area healthcare provider" (ASL), Luciano Mingiacchi, and civil servants for the Lazio regional authorities. According to daily Il Messaggero, Mr Mingiacchi is already being investigated for alleged fraudulent activities related to service commissioning, involving two clinics in the Lazio region.
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.